Healthcare101

  The global Drug Screening Industry is undergoing a major transformation as governments, healthcare systems, employers, and law enforcement agencies intensify efforts to address rising substance abuse and workplace safety concerns. According to the latest analysis, the global drug screening market is projected to grow from USD 10.36 billion in 2025 to USD 21.29 billion by 2030, registering a robust CAGR of 15.5% during the forecast period. The increasing prevalence of polysubstance abuse, growing demand for rapid and accurate testing technologies, stricter workplace compliance regulations, and the expansion of roadside and forensic testing programs are collectively driving market growth worldwide. Download PDF Brochure Rising Polysubstance Use Driving Demand for Advanced Drug Testing One of the primary factors accelerating the growth of the drug screening market is the global rise in polysubstance use. Drug consumption patterns have evolved significantly over the last decade, wi...

 The global healthcare landscape is witnessing a rapid transformation driven by advances in neuroscience and medical technology. Among the most promising areas is neuromodulation , a therapeutic approach that uses electrical or chemical stimulation to alter nerve activity and treat a wide range of chronic conditions. According to recent market analysis, the global Neuromodulation Market , valued at USD 6.81 billion in 2025 , is projected to reach USD 10.68 billion by 2030 , expanding at a robust CAGR of 9.4% during the forecast period. Neuromodulation therapies are increasingly becoming an essential treatment option for patients suffering from neurological disorders, chronic pain, epilepsy, depression, obesity, and ischemic conditions. Continuous technological innovations and expanding healthcare access are further accelerating market growth worldwide. Download PDF Brochure Rising Neurological Disease Burden Driving Market Expansion One of the primary factors fueling the g...

  The global healthcare industry is undergoing a significant transformation as molecular diagnostics continue to reshape infectious disease detection and management. According to MarketsandMarkets, the global Molecular Infectious Disease Testing Market is projected to grow from USD 11.30 billion in 2026 to USD 19.09 billion by 2031, registering a robust CAGR of 11.1% during the forecast period. The report, titled “Molecular Infectious Disease Testing Market by Product & Service (Kits, Instruments), Type (Singleplex, Multiplex), Test Type (Lab, PoC), Disease (STD, Flu, GI, HAI), Technology (PCR, NGS), End User (Diagnostic Labs, Hospitals) – Global Forecast to 2031,” highlights the growing importance of molecular diagnostics in modern healthcare systems. As infectious diseases continue to evolve globally, healthcare providers, diagnostic laboratories, and public health agencies are increasingly relying on advanced molecular testing technologies for rapid, accurate, and reliabl...

  The global Organ Preservation Market is witnessing significant growth as healthcare systems worldwide strive to improve transplantation outcomes and address the increasing burden of organ failure. According to recent market research, the Organ Preservation Market is projected to grow from USD 0.2 billion in 2025 to USD 0.3 billion by 2030, registering a CAGR of 6.8% during the forecast period. The growing demand for organ transplantation, rising prevalence of chronic diseases, technological advancements in preservation techniques, and supportive government initiatives are among the key factors fueling market expansion. As the gap between organ demand and organ availability continues to widen, efficient preservation technologies are becoming increasingly critical in ensuring successful transplantation procedures. Download PDF Brochure Rising Demand for Organ Transplants Driving Market Growth Organ transplantation remains one of the most effective treatment options for patients s...